Skip to main content
Erschienen in: BMC Public Health 1/2023

Open Access 01.12.2023 | Research

Assessment of prevalence and factors affecting Mastalgia among early reproductive-aged women in Bangladesh: a cross-sectional survey

verfasst von: Abu Bakkar Siddique, Sudipto Deb Nath, Mahfuza Mubarak, Amena Akter, Sanjida Mehrin, Mst. Jemi Hkatun, Antara Parvine Liza, Md. Saiful Islam, M. Ziaul Amin, Most. Zannatul Ferdous

Erschienen in: BMC Public Health | Ausgabe 1/2023

Abstract

Background

Mastalgia, or breast pain, is a prevalent and distressing condition experienced by women, impacting their daily lives and causing complications. It is common among women of reproductive age, with associations found with premenstrual syndrome, fibrocystic breast disease, psychological distress, and, in rare cases, breast cancer. While Western societies have high frequencies of Mastalgia, it is less diagnosed in Asian cultures including Bangladesh. This study aimed to investigate the prevalence and factors associated with Mastalgia among early reproductive-aged women in Bangladesh.

Methods

A cross-sectional survey was conducted, and data were collected from different regions of the country. A convenience sampling method was used to take 1,214 participants for the study. A pre-tested semi-structured questionnaire was used to collect data. Bivariate and multivariate analyses were conducted to ascertain factors that were significantly associated with Mastalgia. The data were analyzed using the SPSS software 26 version.

Results

All the participants were female (mean age: 22.87 ± 2.64 years; age ranges: 18–35 years). The prevalence of Mastalgia was found to be 35.5%. The study was conducted using a self-reported semi-structured questionnaire. Participants with a higher education level and higher income were more likely to experience Mastalgia. A family history of breast cancer and severe abdominal pain during menstruation were also identified as associated factors for Mastalgia (p < 0.05).

Conclusions

This study enhances our understanding of Mastalgia in Bangladesh, offering insights for healthcare and policy. Further research is required to uncover its root causes and develop effective interventions. The study highlights the prevalence of mastalgia and its related factors, emphasizing the necessity for increased awareness and support for affected women.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12889-023-17173-7.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AOR
Adjusted Odds Ratio
BDT
Bangladeshi Taka
BMI
Body Mass Index
CI
Confidence Interval
MH
Menstrual Health
OCP
Oral Contraceptive Pill
SD
Standard Deviation
SPSS
Statistical Package for the Social Sciences

Introduction

Mastalgia, commonly known as breast pain, is a frequently encountered and distressing phenomenon among women. It exerts a significant impact on their daily lives, diminishing their quality of life and causing anxiety [1]. This condition is most commonly observed in women aged 15 to 40, a period considered to be within the reproductive age range [1, 2]. Up to two-thirds of women experience Mastalgia at some point during their reproductive years [3]. Mastalgia has been linked to premenstrual syndrome, fibrocystic breast disease, psychological distress, and, in rare instances, breast cancer. Additionally, extramammary conditions such as Tietze syndrome can also lead to Mastalgia [3, 4]. The pain is often described as a dull ache, although some women may encounter sensations of heaviness, tightness, discomfort, or a burning sensation in the breast tissue [4, 5].
Breast pain is typically categorized into two types: cyclic Mastalgia, and noncyclic Mastalgia [4]. It is the most commonly reported concern related to female breast health. Studies conducted in clinical settings have revealed that 67–75% of women under the age of 55 regularly experience breast discomfort before menstruation, and 11–30% report moderate to severe breast pain lasting for five days or more each month [3, 6]. Furthermore, in the United Kingdom, Mastalgia has been observed to have a prevalence as high as 34% among women in the early reproductive age group (18–36 years) due to increased sexual and reproductive activity during this period [7, 8].
In Western societies, Mastalgia, which refers to breast pain without any underlying pathology, is a common complaint that may affect up to 70% of women during their lifetime [9]. Interestingly, it is less prevalent in Asian cultures, affecting as few as 5% of women [10]. While it is not uncommon for women to experience mild breast pain for 2–3 days before menstruation, 8–30% of women report moderate to severe breast pain lasting for five or more days each month [9, 11, 12]. In Bangladesh, a previous study reported that general breast pain was the second most prevalent breast-related complication, with an overall prevalence of 24.22% [13].
The health-related consequences of Mastalgia are significant and difficult to fully articulate. According to certain research, Mastalgia has a detrimental impact on women’s daily activities and diminishes their overall health-related quality of life [10, 14]. In fact, 41% of women with Mastalgia reported a reduced quality of life and decreased sexual engagement, 35% reported poorer sleep quality, and 5% reported a diminished work-life balance [8]. Furthermore, the early reproductive age is a critical period during which women are more likely to engage in sexual and reproductive activities, and breast health is an essential component of their overall well-being [15]. Detecting Mastalgia and its determinants within this age range can contribute to early intervention and prevention strategies, potentially alleviating pain and discomfort [16]. Although numerous factors, including nutrition and psychological and hormonal factors, have been suggested, the exact cause has yet to be determined [17]. Therefore, it is imperative and pressing to investigate factors related to Mastalgia among women in their early reproductive years [18].
In Bangladesh, despite the high burden of breast cancer, little is known about the prevalence and factors affecting Mastalgia among early reproductive-aged women. Early reproductive age is a critical period for women’s reproductive health, and Mastalgia during this period may be indicative of underlying hormonal imbalances or other health conditions [18, 19]. However, the prevalence and risk factors associated with Mastalgia in this population are not well understood Breast-related complications like Mastalgia, Fibroadenoma are commonly underdiagnosed and undertreated in Bangladesh due to societal stigma and prejudice, as well as a scarcity of literature on the subject [20].
Moreover, there is no single study in Bangladesh exactly studying the factors and prevalence of Mastalgia simultaneously. The objective of this study was to examine the prevalence of Mastalgia and its associated factors, particularly those that are modifiable, among women in the early reproductive age group. So, this will be a great resource for our research community and policy makers to take adequate measures and interventions.

Materials and methods

Study area

The study was carried out in different parts of Bangladesh. Data was collected from Dhaka, Rajshahi, Chattogram, Sylhet and Barishal regions of Bangladesh which includes all the major regions of Bangladesh [21].

Sample size

The sample size was calculated using the following equation:
$$n=\frac{{z}^{2}pq}{{d}^{2}}; n=\frac{{1.96}^{2}\times 0.24\times \left(1-0.24\right)}{{0.05}^{2}}=280.28\approx 281$$
Here,
n = number of samples
z = 1.96 (95% confidence level)
p = prevalence estimate (24.22% or 0.24) (based on a previous study)
q = (1-p)
d = Precession of the prevalence estimate (10% of 0.05)
We expected that the current study’s prevalence estimate (p) would be 24%. A sample size of 280.24 ≈ 281 people was estimated based on a 10% non-response rate. This estimate was exceeded by our sample size. However, 1214 participants were recruited to ensure the strength of the study.

Study design, participants, and procedure

The present study employed a self-reported questionnaire-based cross-sectional survey design which was carried out from July to December 2022. The participants were enrolled using a convenience sampling technique. Each participant took approximately 10–15 min to complete the interview. Initially, 1310 participants attended the surveys. After removing incomplete responses, the final analysis included 1214 surveys. The data were gathered using a paper-based semi-structured questionnaire written in Bangla (the participant’s native language) from house to house.
A pilot test was carried out with 10 participants from the same population (target group) to determine the acceptability and transparency of the questionnaire. Following the pilot testing, a few minor adjustments were incorporated into the questionnaire. These data were not included in the final analysis. The first page of the questionnaire had an informed consent statement attached to it that explained the study’s objectives, procedures, and the participant’s right to decline participation. Before starting the survey, “participants were asked to obtain informed consent (i.e., “Are you willing to participate in this study voluntarily and spontaneously?”).The inclusion criteria of the participants included: i) Women at early reproductive age (18 to 35 years of age) [22], ii) experienced menstruation at their reproductive age [1], and iii) living in Bangladesh. The participants below 18 years and over 35 years were excluded at the time of the interview. As menstrual health is a very sensitive issue, the data was collected only by female research assistants and strict confidentiality was maintained.

Measures

Socio-demographic measures and determinants of Mastalgia

Socio-demographic information was gathered by asking questions about age (later categorized as 18–24 years and 25–35 years) [22], marital status (married/ unmarried), education (below university/ university level), occupation (student/ unemployed/ employed/ others), family category (up to 4 members/ more than 4 members), monthly family income (less than 15,000 Bangladeshi Taka [BDT]/ 15,000 BDT to 30,000 BDT/ more than 30,000 BDT) [23] (109.73 BDT = 1 U$D [24]), Relationship status (in a relationship/ single), oral contraceptive [OCP] usage (yes/ no). (See questionnaire in Supplementary file).
Body Mass Index [BMI] (underweight/ normal weight/ overweight) (we measured the height and weight and calculated BMI), extra salt intake during meals (yes/ no), regular fast-food intake (yes/ no), smoking status(yes/ no), social media usage in a day (less than 2 h/ 2 to 5 h/ more than 5 h), soft drink intake (yes/ no), family history of breast cancer (yes/ no), bra usage (yes/ no), and large bra usage (yes/ no) [1, 25].
The menstruation starting age (8 to 11 years/ 12 to 14 years/ more than 14 years), type of menstruation (regular/irregular), the average duration of menstruation (less than 3 days/3 to 6 days/ 7 or more days), amount of blood during menstruation (comparatively low/ normal/high), abdominal pain during menstruation (severe pain/ moderate pain/ no pain), family history of Mastalgia (yes/ no) [1].

Characteristics of Mastalgia and its effect on daily life

Type of breast pain (periodic breast pain/ non-periodic breast pain), pain in both breast (yes/no), pain in both breast (both breast/ one breast), location of breast pain (entire breast/ In a certain area), fever during breast pain (yes/ no), breast pain goes after menstruation starts(yes/no), effects of this pain on daily activities (yes/ no), effect of this pain on daily activities (yes/no), characteristics of the pain (tingling/ throbbing/ stinging/ burning/ cramping/ crushing/ tugging), consulted a doctor for this pain (yes/ no), regular follow-ups (yes/ no), type of diagnostic method used (ultrasonogram/ clinical test or size test/ mammography/ others/ didn’t conduct any diagnostics) multiple responses were taken to this question, The intensity of pain was determined with the aid of a scale graded from 0 to 10, to be very severe at 10 and none at 0 [1, 25].

Dependent variable

The presence of Mastalgia was identified by self-perception of the respondents. The interviewer asked participants, “Do you have swelling and tenderness during or immediately preceding menstruation, as well as breast tissue pain / swelling and tenderness outside of the menstrual period (yes/ no) ? ” [1].

Statistical analysis

All statistical analyses were performed using Microsoft Excel 2019 and SPSS version 26.0 (Chicago, IL, USA). Descriptive statistics, such as frequencies, percentages, averages, and standard deviations (SDs), were computed. Bivariate logistic regression analysis and multivariable logistic regression analysis were used to determine the connection between the dependent and independent variables. Factors found to be significant in the bivariate logistic regression analysis were eventually incorporated in the multivariable logistic regression analysis. For all analyses, a p-value of less than 0.05 was considered statistically significant.

Ethical consideration

The survey was carried out in accordance with the Helsinki Declaration of 1975. The Ethics Review Committee of the Faculty of Biological Science and Technology, Jessore University of Science and Technology, Jessore-7408, Bangladesh [Ref: ERC/FBST/JUST/2022-l-0 L, Date: 13/02/2022] examined and approved the study protocol. All respondents were informed of the study’s goal, procedure, and ability to withdraw their data. Prior to completing the study, each participant provided written informed consent. Participants were advised that all of their information would be kept anonymous and confidential, and they were given information regarding the study’s nature and goal.

Result

General characteristics of participants

A total of 1214 participants (female: 100%) were included in the final analysis. Most of them (87.4%) were aged between 18 and 24 years and 83.9% of them are unmarried. The majority were students (87.1%), had university-level educated (91.4%), were from nuclear families (79.2), came from urban areas (82.2%), and had a family monthly income of more than 30,000 Bangladeshi Taka (BDT; 103.51 BDT = 1US$) (45.9%). Most of the respondents 71.9% are single and didn’t use OCP (oral contraceptive pill).
Almost every (96.6%) respondent had normal body mass index (BMI), while 50.9% took fast food regularly, 42.1% took extra salt in meals, 55.2% drank soft drinks, and 3.2% of respondents smoked. The majority of respondents had no family history of breast cancer (84.3%), used a bra sometimes in a day (64.3%), opted for a perfectly fitting bra (88.0%), and spent 2 to 5 h per day on social media (58.2%). Furthermore, 76.7% of participants reported having regular menstruation, while 74.6% experienced a normal blood flow during menstruation. Most respondents had a menstrual duration lasting between 3 and 6 days (75.1%), with menstruation typically commencing between the ages of 12 to 14 years (75.7%), and moderate abdominal pain occurring during menstruation (58.3%). Notably, 72.5% of the respondents did not have a family history of mastalgia. The overall prevalence of Mastalgia was 35.5% (Table 1).
Table 1
General characteristics of the participants (N = 1,214)
Variables
n (%)
Socioeconomic information
Age
 
18 to 24 years
1061 (87.4)
25 to 35 years
153 (12.6)
Marital status
 
Unmarried
1018 (83.9)
Married
196 (16.1)
Education level
 
Below university
105 (8.6)
University level
1109 (91.04)
Occupation
 
Student
1058 (87.1)
Unemployed
34 (2.8)
Employed
63 (5.2)
Others
59 (4.9)
Place of residence
 
Rural
216 (17.8)
Urban
998 (82.2)
Family Type
 
Nuclear (up to 4 members)
961 (79.2)
Large (more than 4 members)
253 (20.8)
Monthly family income
 
< 15,000 BDT
242 (19.9)
15,000–30,000 BDT
415 (34.2)
> 30,000 BDT
557 (45.9)
Relationship status
 
In a relationship
341 (28.1)
Single
873 (71.9)
OCP Usage
 
Yes
73 (6.0)
No
1141 (94.0)
Basic health-related information
BMI
 
Underweight
192 (15.8)
Normal
840 (96.2)
Overweight
182 (15.2)
Extra salt intake during meals
 
Yes
511 (42.1)
No
703 (57.9)
Regular fast-food intake
 
Yes
618 (50.9)
No
596 (49.1)
Smoking
 
Yes
39 (3.2)
No
1175 (96.8)
Social media usage in a day
 
Less than 2 h
271 (22.3)
2 to 5 h
706 (58.2)
More than 5 h
237 (19.5)
Soft drink intake
 
Yes
670 (55.2)
No
544 (44.8)
Family history of breast cancer
 
Yes
191 (15.7)
No
1023 (84.3)
Bra usage
 
No
132 (10.9)
Sometimes
780 (64.3)
Everyday
302 (24.9)
Large Bra usage
 
Yes
146 (12.0)
No
1068 (88.0)
Menstruation related factors
Menstruation starting age
 
8 to 11 years
199 (16.4)
12 to 14 years
910 (75.0)
More than 14 years
105 (8.6)
Type of menstruation
 
Regular
931 (76.7)
Irregular
283 (23.3)
Average duration of menstruation
 
Less than 3 days
138 (11.4)
3 to 6 days
912 (75.1)
7 or more days
164 (13.5)
Amount of blood during menstruation
 
Comparatively Low
178 (14.7)
Normal
906 (74.6)
High
130 (10.7)
Abdominal pain during menstruation
 
Severe pain
352 (29.0)
Moderate pain
708 (58.3)
No pain
154 (12.7)
Family History of Mastalgia
 
Yes
334 (27.5)
No
880 (72.5)

Descriptive characteristics of Mastalgia

35.5% of the respondents reported that they had Mastalgia. Among those who experienced breast pain, the majority (74.9%) reported having non-periodic breast pain. The majority of respondents who consulted a doctor for breast pain constituted 19.3% of the total. In the study, women reporting pain severity assessed it to be 4.84 ± 2.29 out of 10. The majority of participants experienced pain in both breasts (69.4%). When considering the location of pain, the majority experienced pain throughout the entire breast (51.7%), and 8.8% respondents experienced fever during the pain. In terms of the impact of breast pain, 29.7% reported to have effect on daily activities, while 22.5% reported effect on sleep. Among the characteristics of the pain, the majority of respondents (43.2%) described it as tugging. Furthermore, regular follow-ups were reported by a minority of respondents (8.1%). Only 26.9% respondents conducted any diagnostic tests for determining the cause of the pain (Table 2).
Table 2
Descriptive Characteristics of Mastalgia
Variables
n (%)
Experience of breast pain (Mastalgia)
 
No
783 (64.5)
Yes
431 (35.5)
Type of breast pain
 
Periodic breast pain
108 (25.1)
Non periodic breast pain.
323 (74.9)
The severity and nature of breast pain
 
(n = 431) (x ± SD)
4.84 (2.295)
Pain in both breast
 
Both breast
299 (69.4)
One breast
132 (30.6)
Location of pain
 
Entire breast
223 (51.7)
In a certain area
208 (48.3)
Fever during pain
 
Yes
38 (8.8)
No
393 (91.2)
Breast pain goes after the menstruation starts
 
Yes
331 (76.8)
No
100 (23.2)
Effect of this pain on daily activities
 
Yes
128 (29.7)
No
303 (70.3)
Effect of this pain on sleep
 
Yes
97 (22.5)
No
334 (77.5)
Characteristics of the pain
 
Tingling
99 (23.0)
Throbbing
16 (3.7)
Stinging
84 (19.6)
Burning
18 (4.2)
Cramping
8 (1.9)
Crushing
20 (4.6)
Tugging
186 (43.2)
Consulted a doctor for breast pain
 
Yes
83 (19.3)
No
348 (80.7)
Regular follow-ups
 
Yes
35 (8.1)
No
396 (91.9)
Type of diagnostic tests used
 
Ultrasonogram
56 (13.0)
Clinical test/Size test
42 (9.7)
Mammography
12 (2.8)
Others
6 (1.4)
Didn’t conduct any diagnostics
315 (73.1)

Regression analysis

Table 3 shows the result of binary logistic regression analysis by self-reported Mastalgia occurrence. All the variables were included in the adjusted models. As per the adjusted binary logistic analysis, participants from the below university group were less likely to have Mastalgia compared to the University level group (AOR = 0.57, 95% CI = 0.34–0.98, p = 0.044). Higher odds of Mastalgia were found among participants who had monthly family income of more than 30,000 BDT (AOR = 1.50, 95% CI = 1.02–2.22, p = 0.037) compared to the lower income group (less than 15,000 BDT).
Table 3
Binary and multiple regression analysis of factors associated with Mastalgia
Variables
Yes (%)
NO (%)
Unadjusted model
Adjusted modela
COR (95% CI)
p-value
AOR (95% CI)
p-value
Socioeconomic information
Age
18 to 24 years
370 (30.5)
691 (56.9)
Reference
 
Reference
 
25 to 35 years
61 (5.0)
92 (7.6)
1.23 (1.036–1.931)
0. 0.228
0.93 (0.55–1.57)
0.800
Marital status
Unmarried
348 (28.7)
670 (55.2)
Reference
 
Reference
 
Married
83 (6.8)
113 (9.3)
1.41 (0.51–0.96)
0.029
1.09 (0.69–1.72)
0.696
Education level
Below university
29 (2.4)
76 (6.3)
0.67 (0.43–1.04)
0.079
0.57 (0.34–0.98)
0.044
University level
402 (33.1)
707 (58.2)
Reference
 
Reference
 
Occupation
Student
369 (30.4)
689 56.8)
Reference
 
Reference
 
Unemployed
8 (0.7)
26 (2.1)
0.57 (0.25–1.28)
0.176
0.71 (0.27–1.82)
0.480
Employed
32 (2.6)
31 (2.6)
1.92 (1.15–3.20)
0.012
1.34 (0.67–2.71)
0.402
Others
22 (1.8)
37 (3.0)
1.11 (0.64-1.91)
0.706
1.34 (0.59–3.03)
0.476
Place of residence
Rural
66 (5.4)
150 (12.4)
0.76 (0.55–1.04)
0.094
1.39 (0.98–1.97)
0.063
Urban
365 (30.1)
633 (52.1)
Reference
 
Reference
 
Family Type
Nuclear
349 (28.7)
612 (50.4)
1.18 (0.88–1.59)
0.248
0.91 (0.63–1.31)
0.624
Large
82 (6.8)
171 (14.1)
Reference
 
Reference
 
Monthly family income
< 15,000 BDT
66 (5.4)
176 (14.5)
Reference
 
Reference
 
15,000–30,000 BDT
146 (12.0)
269 (22.2)
1.44 (1.02–2.04)
0.037
1.32 (0.89–1.95)
0.167
> 30,000 BDT
219 (18.0)
338 (27.8)
1.72 (1.24–2.40)
0.001
1.50 (1.02–2.22)
0.037
Relationship status
Yes
147 (12.1)
194 (16.0)
1.57 (1.21–2.03)
0.001
1.29 (0.95–1.76)
0.095
No
284 (23.4)
589 (48.5)
Reference
 
Reference
 
OCP Usage
Yes
34 (2.8)
39 (3.2)
1.63 (1.015–2.62)
0.043
0.90 (0.46–1.75)
0.759
No
397 (32.7)
744 (61.3)
Reference
 
Reference
 
Basic health related information
BMI
Underweight
58 (4.8)
134 (11.0)
Reference
 
Reference
 
Normal
312 (25.7)
528 (43.5)
1.36 (0.97–1.91)
0.071
1.16 (0.79–1.70)
0.444
Overweight
61 (5.0)
121 (10.0)
1.16 (0.75–1.80)
0.493
0.81 (0.48–1.34)
0.420
Extra salt intake
Yes
201 (16.6)
310 (25.5)
1.33 (1.05–1.69)
0.017
1.26 (0.96–1.66)
0.091
No
230 (18.9)
473 (39.0)
Reference
 
Reference
 
Regular fast-food intake
 
Yes
240 (19.8)
378 (31.1)
1.34 (1.06–1.70)
0.014
1.02 (0.75–1.38)
0.889
No
191(15.7)
405 (33.4)
Reference
   
Smoking
Yes
20 (1.6)
19 (1.6)
1.95 (1.03–3.70)
0.040
1.13 (0.53–2.42)
0.740
No
411 (33.9)
764 (62.9)
Reference
 
Reference
 
Social media usage in a day
Less than 2 h
77 (6.3)
194 (16.0)
Reference
 
Reference
 
2 to 5 h
256 (21.1)
450 (37.1)
1.43 (1.05–1.94)
0.021
1.15 (0.81–1.63)
0.434
More than 5 h
98 (8.1)
139 (11.4)
1.776 (1.228–2.57)
0.002
1.35 (0.88–2.07)
0.162
Soft drink intake
Yes
268 (22.1)
402 (33.1)
1.55 (1.22–1.98)
< 0.001
1.29 (0.95–1.76)
0.100
No
163 (13.4)
381 (31.4)
Reference
 
Reference
 
Family history of breast cancer
Yes
97 (8.0)
94 (7.7)
2.12 (1.55–2.90)
< 0.001
1.80 (1.26–2.58)
0.001
No
334 (27.5)
689 (56.8)
Reference
 
Reference
 
Bra usage
No
37 (3.0)
95 (7.8)
0.94 (0.60–1.49)
0.814
0.97 (0.57–1.63)
0.917
Sometimes
306 (25.2)
474 (39.0)
1.57 (1.17–2.09)
0.002
1.42 (1.03–1.96)
0.029
Everyday
88 (7.2)
214 (17.6)
Reference
   
Large Bra usage
Yes
68 (5.6)
78 (6.4)
1.69 (1.19–2.40)
0.003
1.24 (0.83–1.87)
0.284
No
363 (29.9)
705 (58.1)
Reference
 
Reference
 
Menstruation related factors
Menstruation starting age
8 to 11 years
80 (6.6)
119 (9.8)
1.94 (1.15–3.27)
0.013
1.48 (0.83–2.66)
0.180
12 to 14 years
324 (26.7)
586 (48.3)
1.59 (1.01–2.52)
0.045
1.42 (0.86–2.35)
0.170
More than 14 years
27 (2.2)
78 (6.4)
Reference
 
Reference
 
Type of menstruation
Regular
327 (26.9)
604 (49.8)
Reference
 
Reference
 
Irregular
104 (8.6)
179 (14.7)
1.07 (0.81–1.41)
0.617
0.94 (0.67–1.32)
0.734
Duration of menstruation
Less than 3 days
61 (5.0)
77 (6.3)
1.48 (0.93–2.36)
0.094
0.83 (0.44–1.55)
0.565
3 to 6 days
313 (25.8)
599 (49.3)
0.98 (0.69–1.39)
0.981
0.85 (0.55–1.29)
0.448
7 or more days
57 (4.7)
107 (8.8)
Reference
 
Reference
 
Amount of blood during menstruation
Comparatively Low
80 (6.6)
98 (8.1)
Reference
 
Reference
 
Normal
297 (24.5)
609 (50.2)
0.59 (0.43 − 0.08)
0.002
0.66 (0.42–1.03)
0.068
High
54 (4.4)
76 (6.3)
0.87 (0.55–1.37)
0.552
0.80 (0.43–1.47)
0.483
Abdominal pain during menstruation
Severe pain
157 (12.9)
195 (16.1)
2.639 (1.72–4.050)
< 0.001
2.40 (1.49–3.87)
< 0.001
Moderate pain
238 (19.6)
470 (38.7)
1.66 (1.10–2.48)
0.014
1.48 (0.95–2.31)
0.078
No pain
36 (3.0)
118 (9.7)
Reference
 
Reference
 
Family History of Mastalgia
Yes
209 (17.2)
125 (10.3)
4.95 (3.78–6.48)
< 0.001
4.37 (3.27–5.83)
< 0.001
No
222 (18.3)
658 (54.2)
Reference
 
Reference
 
Notes: COR = Unadjusted/ Crude odds ratio; CI = Confidence interval; AOR = Adjusted odds ratio
Participants having a family history of breast cancer were approximately two times more likely to have Mastalgia compared to those having no family history (AOR = 1.80, 95% CI = 1.26–2.58, p = 0.001). Those who had severe abdominal pain during the menstruation were two times more likely to have Mastalgia compared to those who didn’t have any pain during the menstruation (AOR = 2.40, 95% CI = 1.49–3.87, p = < 0.001). In addition, participants who had a family history of Mastalgia were four times more likely to have Mastalgia compared to those having no family history (AOR = 4.37, 95% CI = 3.27–5.83, p = < 0.001).
Figure 1 depicts the problems before starting menstruation. 30% and 19.41% of the respondents reported that they experienced waist pain and bad temper respectively.

Discussion

Breast pain known as Mastalgia arises from the breast tissue and is one of the most common breast symptoms among reproductive-aged women [2]. Its impact on quality of life is frequently underestimated and may be severe enough to interfere with routine everyday tasks all over the country, including Bangladesh [10, 26]. Mastalgia, considered one of our country’s major public health issues, is the leading common breast-related problem among women in both developed and developing countries, including Bangladesh. Adjusted binary logistic analysis revealed significant associations: lower university group participants had lower odds of Mastalgia compared to those at the university level; individuals with a monthly family income exceeding 30,000 BDT had higher odds of Mastalgia compared to the lower-income group; participants with a family history of breast cancer were approximately twice as likely to experience Mastalgia as those without such a history; individuals with severe menstrual abdominal pain had a higher likelihood of Mastalgia compared to those without pain; and those with a family history of Mastalgia were more likely to have Mastalgia compared to those without such a history.
Our study revealed that about one-third (35.5%) of the participants had experienced Mastalgia. There is no single study investigating the associated factors of Mastalgia in Bangladesh. Other studies in different parts of the world exploring Mastalgia show varying data. For example, in India, 47.33% of women experience Mastalgia [27], compared to 33% in Iran [25]. About 68% of women in the USA, 51.5% of women in Canada, and 32% in the UK have been reported to experience Mastalgia [27]. The prevalence of Mastalgia in Sub-Saharan Africa and China are 16% and 45.3% respectively [28, 29]. Factors associated with Mastalgia include higher age, university graduate, BMI of > 30, excessive use of salt, use of a small bra, and use of a large bra were in line with Turkish study [30].
In our study, 2.4% of the below university level & 33.1% of the university level suffer from Mastalgia and university graduates are more prone to Mastalgia. This is in line with Egyptian and Turkish studies where graduates from university suffered more from Mastalgia [28, 30]. It’s not clear if is there any relationship between Mastalgia and education level. Further study is needed to know what is the cause of Mastalgia at the higher education level.
The study results are consistent with other studies that have reported an association between socioeconomic status and Mastalgia. For instance, a study conducted in the United States reported a higher prevalence of Mastalgia among women with higher income and education levels [31]. On the other hand, a study conducted in Iran reported no association between Mastalgia among women and socioeconomic status [32].
The findings of the study also suggest that genetic factors may play a role in Mastalgia occurrence. Women with a family history of breast cancer or Mastalgia were more likely to have Mastalgia. These findings are consistent with other studies that have reported an association between a family history of breast cancer and Mastalgia [33]. Another study in Iraq also found that there is a strong relationship positive family history of breast cancer and Mastalgia [34]. There is compelling evidence that breast cancer can lead to breast pain, establishing a connection between Mastalgia and breast edema and stroma [33].
Furthermore, the study results highlight the importance of severe abdominal pain during the menstruation as a risk factor for Mastalgia. Previous studies have also reported an association between menstrual pain and Mastalgia. A study conducted in Saudi Arabia reported a higher prevalence of Mastalgia among women who experienced severe menstrual pain [35]. Additionally, Mastalgia is highly related to menstruation [1].
Furthermore, we found an association between a family history of Mastalgia and Mastalgia cases. This is a similar finding according to a prospective study of turkey [33], indicating a clear relationship between genetic factors and Mastalgia [36].
In our study, we didn’t find any relationship between Mastalgia who had a history of smoking. But there are some studies where they found a close relationship between Mastalgia who had a smoking history [36, 37]. Further study is needed to clarify of this association.
Some studies found positive association between Mastalgia and BMI [30, 38]. But in our, we didn’t find any relationship between BMI and Mastalgia. So, the environmental cause may also be related to Mastalgia. Further study is needed to evaluate Mastalgia that is there any association that leads to Mastalgia.

Limitations

It is worth noting that the study has a few limitations. One of the main limitations is that the study relies on self-reported data, which may introduce bias or error. Participants may have different interpretations of what constitutes Mastalgia or may be more or less likely to report symptoms based on factors such as cultural beliefs or social desirability bias. Another limitation is that the study is cross-sectional, which means that causality cannot be inferred. It is not possible to know whether the risk factors identified in this study directly cause Mastalgia or whether they are simply associated with it. Furthermore, the study was conducted in Bangladesh, and the results may not be generalizable to other populations.

Conclusion

Despite these limitations, the study’s findings highlight several potential associated factors for Mastalgia, including family history of breast cancer or Mastalgia, severe abdominal pain during menstruations, higher income, and higher educational status. Clinicians may want to consider these factors when assessing patients who report symptoms of Mastalgia. Furthermore, the findings suggest that public health interventions may be needed to reduce the burden of Mastalgia among certain populations, such as those with a family history of breast cancer or those with severe menstrual pain.

Acknowledgements

The authors would like to express the most profound gratitude to all of the respondents who participated in this study. Additionally, authors also would like to thank all the research assistants for helping data collection voluntarily: Asha Afrin, Drishti Deb Nath, Jannatul Arobia, Mst Murshida Khatun, Nayema Suchana, Pranti Chowdhury, Shabnaj Mustari, Shumaiya Shammmi Bili, Zhilik Das.

Declarations

The study had been carried out in conformity with the Helsinki Declaration and institutional rules for research ethics involving human subjects. The Ethics Review Committee of the Faculty of Biological Science and Technology, Jessore University of Science and Technology, Jessore-7408, Bangladesh [Ref: ERC/FBST/JUST/2022-l-0 L, Date: 13/02/2022] examined and approved the study protocol. All respondents were informed of the study’s goal, procedure, and ability to withdraw their data. Prior to completing the study, each participant provided written informed consent.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
4.
Zurück zum Zitat Olawaiye A, Withiam-Leitch M, Danakas G, Kahn K. “Mastalgia: a review of management.,” J. Reprod. Med, vol. 50, no. 12, pp. 933–939, Dec. 2005. Olawaiye A, Withiam-Leitch M, Danakas G, Kahn K. “Mastalgia: a review of management.,” J. Reprod. Med, vol. 50, no. 12, pp. 933–939, Dec. 2005.
9.
Zurück zum Zitat Ernster VL et al. “Effects of caffeine-free diet on benign breast disease: a randomized trial.,” Surgery, vol. 91, no. 3, pp. 263–267, Mar. 1982. Ernster VL et al. “Effects of caffeine-free diet on benign breast disease: a randomized trial.,” Surgery, vol. 91, no. 3, pp. 263–267, Mar. 1982.
10.
Zurück zum Zitat Salzman B, Collins E, Hersh L. “Common Breast Problems.,” Am. Fam. Physician, vol. 99, no. 8, pp. 505–514, Apr. 2019. Salzman B, Collins E, Hersh L. “Common Breast Problems.,” Am. Fam. Physician, vol. 99, no. 8, pp. 505–514, Apr. 2019.
12.
Zurück zum Zitat Salzman B, Fleegle S, Tully AS. “Common breast problems.,” Am. Fam. Physician, vol. 86, no. 4, pp. 343–349, Aug. 2012. Salzman B, Fleegle S, Tully AS. “Common breast problems.,” Am. Fam. Physician, vol. 86, no. 4, pp. 343–349, Aug. 2012.
18.
Zurück zum Zitat Akter MF, Ullah MO. “Awareness levels of breast cancer among female university and medical college students in Sylhet city of Bangladesh.,” Cancer reports (Hoboken, N.J.), vol. 5, no. 11, p. e1608, Nov. 2022, https://doi.org/10.1002/cnr2.1608 Akter MF, Ullah MO. “Awareness levels of breast cancer among female university and medical college students in Sylhet city of Bangladesh.,” Cancer reports (Hoboken, N.J.), vol. 5, no. 11, p. e1608, Nov. 2022, https://​doi.​org/​10.​1002/​cnr2.​1608
25.
Zurück zum Zitat Vaziri F, Samsami A, Rahimi Z, Rastgardoost N, Nick N. Prevalence, severity and factors related to Mastalgia among women referring to Health centers affiliated with Shiraz University of Medical Sciences. J Heal Sci Survellience Syst. 2016;4(2):4–9. Vaziri F, Samsami A, Rahimi Z, Rastgardoost N, Nick N. Prevalence, severity and factors related to Mastalgia among women referring to Health centers affiliated with Shiraz University of Medical Sciences. J Heal Sci Survellience Syst. 2016;4(2):4–9.
35.
Zurück zum Zitat AlJbeery AS, AlShaifani AA, AlMutlaq SM, Salati SA. Mastalgia-A study from the Middle East. Online J Heal Allied Sci. 2017;16(4):14. AlJbeery AS, AlShaifani AA, AlMutlaq SM, Salati SA. Mastalgia-A study from the Middle East. Online J Heal Allied Sci. 2017;16(4):14.
Metadaten
Titel
Assessment of prevalence and factors affecting Mastalgia among early reproductive-aged women in Bangladesh: a cross-sectional survey
verfasst von
Abu Bakkar Siddique
Sudipto Deb Nath
Mahfuza Mubarak
Amena Akter
Sanjida Mehrin
Mst. Jemi Hkatun
Antara Parvine Liza
Md. Saiful Islam
M. Ziaul Amin
Most. Zannatul Ferdous
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2023
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-17173-7

Weitere Artikel der Ausgabe 1/2023

BMC Public Health 1/2023 Zur Ausgabe